Completeness Assessment of Type II Active Pharmaceutical Ingredient Drug Master Files under Generic Drug User Fee Amendment: Review Metrics and Common Incomplete Items

Benzer Materyaller

• The generic drug user fee amendments: an economic perspective
  Yazar:: Berndt, Ernst R, ve diğerleri
  Baskı/Yayın Bilgisi: (2018)
• WTO amendment on generic drugs draws mixed reaction
  Yazar:: Zarocostas, John
  Baskı/Yayın Bilgisi: (2005)
• FDA Critical Path Initiatives: Opportunities for Generic Drug Development
  Yazar:: Lionberger, Robert A.
  Baskı/Yayın Bilgisi: (2008)
• Quality Assurance of Chemical Ingredient Classification for the National Drug File – Reference Terminology
  Yazar:: Zheng, Ling, ve diğerleri
  Baskı/Yayın Bilgisi: (2017)
• Similarities and Differences of International Practices and Procedures for the Regulation for Active Substance Master Files/Drug Master Files of Human Use: Moving Toward Regulatory Convergence
  Yazar:: Maki Matsuhama, ve diğerleri
  Baskı/Yayın Bilgisi: (2016-08-01)